- Tools
- Downloads
- Links
- Community
- About
- Help
FB2026_01
,
released March 12, 2026
[47E5-47E5];[47F8-47F8];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
47E5;47F8
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(2R)ED2155.
The presence of P+PBac{XP5.WH5}BSC358 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(2R)BSC358 predicted from the Release 5 insertions sites are 47E5;47F8. (Exelixis, Inc. determined the insertion site of P{XP}d05203 to be at Release 3 genomic coordinate 6448708 on chromosome arm 2R. The Gene Disruption project determined the insertion site of P{XP}d05203 to be at Release 3 genomic coordinate 6448962 on arm 2R. This corresponds to 47F8 on both the Release 3 and 5 genome maps. The predicted position of PBac{WH}CG9067f01295 on the Release 5 map is 47E5.)